KALII PERMANGANAS pulvis 20g
POTASSIUM PERMANGANATE
BRIEF DESCRIPTION OF THE PRODUCT
1. Trade name of the medicinal product
POTASSIUM PERMANGANATE
2. Quantitative and qualitative composition
Name of the ingredient Potassium Permanganate
Quantity in one package 20 g
Pharmacopoeia Ph. Euro 4
3. Pharmaceutical form
Powder for dermal solution.
4. Clinical data
4.1. Indications
Externally in the form of an aqueous solution for disinfecting wounds.
4.2. Dosage and method of use
Externally: for disinfection in the form of an aqueous solution 0.01% to 0.1% (the resulting solution should be pale pink in color). Usage: apply liberally with a suitable cotton swab or as directed by a physician.
4.3. Contraindications
Hypersensitivity to potassium permanganate.
4.4. Special warnings and special precautions for use
Do not apply undiluted!
Keep out of the reach of children!
Avoid contact with eyes!
It is desirable to use a daily solution!
4.5. Drug and other interactions
Not known.
4.6. Pregnancy and breastfeeding
No data.
4.7. Effects on the ability to drive and use machines
Not known.
4.8. Adverse drug reactions
Allergic reactions are possible.
4.9. Overdose
Directly applied and as a high concentration solution causes tissue necrosis.
5. Pharmacological data
5.1. Pharmacodynamic properties (pharmacotherapeutic group, mechanism of action, pharmacodynamic effects)
When potassium permanganate comes into contact with organic matter, oxygen is released in an atomic state, which determines its antiseptic and deodorizing effect.
5.2. Pharmacokinetic properties (absorption, distribution, biotransformation, elimination)
It is not absorbed through the skin and mucous membrane.
5.3. Preclinical safety data
No data.
6. Pharmaceutical data
6.1. List of excipients and their amounts
There is no.
6.2. Physico-chemical incompatibilities
They are not observed
6.3. Expiry date
5 (five) years.
6.4. Special storage conditions
In original packaging, in a dry place protected from direct sunlight, at a temperature below 25°C.
